|1.||Fujimori, Minoru: 8 articles (09/2010 - 03/2002)|
|2.||Taniguchi, Shun'ichiro: 6 articles (09/2010 - 03/2002)|
|3.||Amano, Jun: 5 articles (09/2010 - 03/2002)|
|4.||Sasaki, Takayuki: 5 articles (09/2010 - 11/2002)|
|5.||Ha, Nam Joo: 4 articles (11/2015 - 12/2005)|
|6.||Zeng, Zhongming: 4 articles (05/2013 - 08/2010)|
|7.||Huang, Zhen: 4 articles (05/2013 - 08/2010)|
|8.||Zeng, Weiseng: 4 articles (05/2013 - 08/2010)|
|9.||Yu, Zhijian: 4 articles (05/2013 - 08/2010)|
|10.||Iwatsuki, Keiji: 4 articles (01/2011 - 03/2007)|
|1.||Falciparum Malaria (Plasmodium falciparum Malaria)
03/01/1978 - "These findings suggest that acetylator phenotype does not influence the therapeutic response of individuals infected with falciparum malaria to sulfalene or to the combination of sulfalene and pyrimethamine. "
03/01/1978 - "The influence of acetylator phenotype on the response to sulfalene in individuals with chloroquine-resistant falciparum malaria."
11/01/1971 - "Treatment of falciparum malaria with sulfalene and trimethoprim."
07/01/1971 - "Treatment of acute falciparum malaria from Vietnam with trimethoprim and sulfalene."
07/28/1969 - "Sulfalene and trimethoprim in acute falciparum malaria."
06/01/2012 - "To investigate the cell viability of Bifidobacterium longum 5(1A) in fermented milks and to study its immunostimulating and protective capacity against Salmonella enterica ssp. enterica serovar Typhimurium infection in mice. "
01/01/2015 - "Bifidobacterium longum MM-2 (MM-2), a very safe bacterium in humans, was isolated from healthy humans and its protective effect against IFV infection in a murine model shown. "
05/01/2013 - "longum expressing the VP1 protein might successfully elicit a specific immune response against EV71 infection."
05/01/2013 - "longum that could be used to develop an oral vaccine against EV71 infection. "
01/01/2011 - "longum can be used to treat virus infection still remains elusive. "
01/01/2008 - "To determine the efficacy of a combination of Bifidobacterium longum PL03, Lactobacillus rhamnosus KL53A and Lactobacillus plantarum PL02 for the prevention of antibiotic-associated diarrhea in children. "
05/01/2006 - "A multicenter, parallel-group, randomized, double-blind, active-controlled clinical trial, involving 169 outpatients at 9 centers, was conducted to assess the efficacy of a fixed bacterium combination of Lactobacillus gasseri and Bifidobacterium longum in the therapy of acute diarrhea. "
01/01/2008 - "Bifidobacterium longum PL03, Lactobacillus rhamnosus KL53A, and Lactobacillus plantarum PL02 in the prevention of antibiotic-associated diarrhea in children: a randomized controlled pilot trial."
01/01/2014 - "Acute diarrhea is the most studied disease for which bifidobacteria are applied with great success, Bifidobacterium longum and Bifidobacterium breve being the most applied species. "
05/01/2006 - "Oral therapy with a fixed combination of Lactobacillus gasseri and Bifidobacterium longum shortens the duration and decreases the severity of acute self-limiting diarrhea in adults comparable to an effective mono-bacterium medicinal product. "
|4.||Seasonal Allergic Rhinitis (Hay Fever)
03/01/2007 - "Clinical efficacy of probiotic Bifidobacterium longum for the treatment of symptoms of Japanese cedar pollen allergy in subjects evaluated in an environmental exposure unit."
01/01/2007 - "We have previously reported the results of a randomized, double-blind, placebo-controlled trial that found the intake of yogurt supplemented with a probiotic strain, Bifidobacterium longum BB536, alleviates symptoms and affects blood parameters in individuals with Japanese cedar pollinosis (JCPsis) during the pollen season. "
11/01/2006 - "The present study investigated the effects of probiotic strain Bifidobacterium longum BB536 in the treatment of Japanese cedar pollinosis (JCPsis). "
01/01/2006 - "This study tested the effect of a yogurt supplemented with a probiotic strain Bifidobacterium longum BB536 in the treatment of Japanese cedar pollinosis (JCPsis). "
10/01/2007 - "Influence of Bifidobacterium longum BB536 intake on faecal microbiota in individuals with Japanese cedar pollinosis during the pollen season."
03/01/1978 - "When sulfalene was administered during malaria, this difference was no longer apparent. "
03/01/1978 - "Following the administration of sulfalene before infection with malaria, a significant difference in half-life of non-acetylated sulfalene and percent acetylation of sulfalene in plasma was observed between rapid and slow acetylators. "
01/01/2007 - "Sulphadoxine/sulphalene-pyrimethamine (SP) was adopted in Kenya as first line therapeutic for uncomplicated malaria in 1998. "
02/01/1975 - "Host failure in treatment of malaria with sulfalene and pyrimethamine."
07/01/1968 - "[Comparative study of the association of sulfalene and pyrimethamine and of sulfalene alone in mass chemoprophylaxis of malaria]."